Literature DB >> 10772644

Poxvirus vectors: orphaned and underappreciated.

M J Mastrangelo1, L C Eisenlohr, L Gomella, E C Lattime.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10772644      PMCID： PMC300840          DOI： 10.1172/JCI9819

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  11 in total

Review 1.  Strategies in the development of recombinant vaccines for colon cancer.

Authors:  J Schlom; K Y Tsang; J A Kantor; S I Abrams; S Zaremba; J Greiner; J W Hodge
Journal:  Semin Oncol       Date:  1999-12       Impact factor: 4.929

2.  New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins.

Authors:  A J Davison; B Moss
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

3.  Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma.

Authors:  M J Mastrangelo; H C Maguire; L C Eisenlohr; C E Laughlin; C E Monken; P A McCue; A J Kovatich; E C Lattime
Journal:  Cancer Gene Ther       Date:  1999 Sep-Oct       Impact factor: 5.987

Review 4.  Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

Authors:  B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 5.  Applications of pox virus vectors to vaccination: an update.

Authors:  E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Authors:  G Dranoff; E Jaffee; A Lazenby; P Golumbek; H Levitsky; K Brose; V Jackson; H Hamada; D Pardoll; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA.

Authors:  G L Smith; B Moss
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

8.  Nonreplicating vaccinia vector efficiently expresses recombinant genes.

Authors:  G Sutter; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  Intravesical gene therapy: in vivo gene transfer using recombinant vaccinia virus vectors.

Authors:  S S Lee; L C Eisenlohr; P A McCue; M J Mastrangelo; E C Lattime
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

Review 10.  In situ cytokine gene transfection using vaccinia virus vectors.

Authors:  E C Lattime; S S Lee; L C Eisenlohr; M J Mastrangelo
Journal:  Semin Oncol       Date:  1996-02       Impact factor: 4.929
View more
  8 in total

1.  Delivery strategies for novel vaccine formulations.

Authors:  Maria Trovato; Shelly J Krebs; Nancy L Haigwood; Piergiuseppe De Berardinis
Journal:  World J Virol       Date:  2012-02-12

2.  Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC.

Authors:  Yilin C Neeley; Kevin T McDonagh; Willem W Overwijk; Nicholas P Restifo; Martin G Sanda
Journal:  Prostate       Date:  2002-11-01       Impact factor: 4.104

Review 3.  The use of viral vectors in vaccine development.

Authors:  Tatianna Travieso; Jenny Li; Sneha Mahesh; Juliana Da Fonzeca Redenze E Mello; Maria Blasi
Journal:  NPJ Vaccines       Date:  2022-07-04       Impact factor: 9.399

Review 4.  The immunologic aspects of poxvirus oncolytic therapy.

Authors:  Andrea Worschech; D Haddad; D F Stroncek; E Wang; Francesco M Marincola; Aladar A Szalay
Journal:  Cancer Immunol Immunother       Date:  2009-03-06       Impact factor: 6.968

Review 5.  Therapeutic vaccines for non-Hodgkin B-cell lymphoma.

Authors:  Javier Briones
Journal:  Clin Transl Oncol       Date:  2008-09       Impact factor: 3.340

6.  Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68.

Authors:  Maria Libera Ascierto; Andrea Worschech; Zhiya Yu; Sharon Adams; Jennifer Reinboth; Nanhai G Chen; Zoltan Pos; Rahul Roychoudhuri; Giovanni Di Pasquale; Davide Bedognetti; Lorenzo Uccellini; Fabio Rossano; Paolo A Ascierto; David F Stroncek; Nicholas P Restifo; Ena Wang; Aladar A Szalay; Francesco M Marincola
Journal:  BMC Cancer       Date:  2011-10-19       Impact factor: 4.430

7.  Ectopic expression of vaccinia virus E3 and K3 cannot rescue ectromelia virus replication in rabbit RK13 cells.

Authors:  Erin S Hand; Sherry L Haller; Chen Peng; Stefan Rothenburg; Adam R Hersperger
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

Review 8.  Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats.

Authors:  Sophia M Vrba; Natalie M Kirk; Morgan E Brisse; Yuying Liang; Hinh Ly
Journal:  Vaccines (Basel)       Date:  2020-11-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.